References
- GutkinACohenZRPeerDHarnessing nanomedicine for therapeutic intervention in glioblastomaExpert Opin Drug Deliv201613111573158227292970
- HottingerAFStuppRHomicskoKStandards of care and novel approaches in the management of glioblastoma multiformeChin J Cancer2014331323924384238
- BernardiABraganholEJägerEIndomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma modelCancer Lett20092811536319286307
- SonaliViswanadhMKSinghRPNanotheranostics: emerging strategies for early diagnosis and therapy of brain cancerNanotheranostics201821708629291164
- StephenZRKievitFMVeisehORedox-responsive magnetic nanoparticle for targeted convection-enhanced delivery of O(6)-benzylguanine to brain tumorsACS Nano2014810103831039525247850
- TabatabaeiSNGirouardHCarretA-SMartelSRemote control of the permeability of the blood-brain barrier by magnetic heating of nanoparticles: a proof of concept for brain drug deliveryJ Control Release2015206495725724273
- Fontes de Paula AguiarMBustamante MamaniJKlei FelixTMagnetic targeting with superparamagnetic iron oxide nanoparticles for in vivo gliomaNanotechnol Rev201765449472
- MaHLXuYFQiXRMaitaniYNagaiTSuperparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancersInt J Pharm2008354121722618191350
- DanhierFLecouturierNVromanBPaclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluationJ Control Release20091331111718950666
- ZhaoMLiangCLiAMagnetic paclitaxel nanoparticles inhibit glioma growth and improve the survival of rats bearing glioma xenograftsAnticancer Res20103062217222320651372
- ShahNChaudhariKDantuluriPMurthyRSRDasSPaclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic®P85, an in vitro cell line and in vivo biodistribution studies on rat modelJ Drug Target200917753354219530913
- LiDYangKLiJ-SAntitumor efficacy of a novel CLA-PTX microemulsion against brain tumors: in vitro and in vivo findingsInt J Nanomedicine201276105611423269869
- SchleichNSibretPDanhierPDual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imagingInt J Pharm201344719410123485340
- SchleichNPoCJacobsDComparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapyJ Control Release2014194829125178270
- FreichelsHDanhierFPréatVLecomtePJérômeCFluorescent labeling of degradable poly(lactide-co-glycolide) for cellular nanoparticles tracking in living cellsInt J Artif Organs201134215216021374567
- GarinotMFiévezVPourcelleVPEGylated PLGA-based nanoparticles targeting M cells for oral vaccinationJ Control Release2007120319520417586081
- MassartRPreparation of aqueous magnetic liquids in alkaline and acidic mediaIEEE Trans Magn198117212471248
- MiyazawaTNakagawaKHarigaeTDistribution of β-carotene-encapsulated polysorbate 80-coated poly(D, L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administrationInt J Nanomedicine2015107223723026664113
- DanhierPDe PreterGBoutrySElectron paramagnetic resonance as a sensitive tool to assess the iron oxide content in cells for MRI cell labeling studiesContrast Media Mol Imaging20127330230722539400
- DanhierFPourcelleVMarchand-BrynaertJJérômeCFeronOPréatVChapter eight – targeting of tumor endothelium by RGD-grafted PLGA-nanoparticlesDüzgüneşNMethods in Enzymology508San DiegoAcademic Press2012157175
- DanhierFMessaoudiKLemaireLBenoitJ-PLagarceFCombined anti-galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluationInt J Pharm2015481115416125644286
- BiancoJBastiancichCJoudiouNGallezBdes RieuxADanhierFNovel model of orthotopic U-87 MG glioblastoma resection in athymic nude miceJ Neurosci Methods20172849610228472680
- LetenCStruysTDresselaersTHimmelreichUIn vivo and ex vivo assessment of the blood brain barrier integrity in different glioblastoma animal modelsJ Neurooncol2014119229730624990826
- HeyeAKCullingRDValdés HernándezMDCThrippletonMJWardlawJMAssessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic reviewNeuroimage Clin2014626227425379439
- WangBLvLWangZImproved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxelSci Rep201551658926567528
- GuGXiaHHuQPEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapyBiomaterials201334119620823069707
- BaeYHParkKTargeted drug delivery to tumors: myths, reality and possibilityJ Control Release2011153319820521663778
- MundargiRCBabuVRRangaswamyVPatelPAminabhaviTMNano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivativesJ Control Release2008125319320918083265
- JiangYWangXLiuXEnhanced antiglioma efficacy of ultrahigh loading capacity paclitaxel prodrug conjugate self-assembled targeted nanoparticlesACS Appl Mater Interfaces20179121121727976583
- ZhuX-MWangY-XJLeungKC-FEnhanced cellular uptake of aminosilane-coated superparamagnetic iron oxide nanoparticles in mammalian cell linesInt J Nanomedicine2012795396422393292
- WeaverBAHow Taxol/paclitaxel kills cancer cellsMol Biol Cell201425182677268125213191
- OhNParkJ-HEndocytosis and exocytosis of nanoparticles in mammalian cellsInt J Nanomedicine20149Suppl 1516324872703
- YameenBChoiWIVilosCSwamiAShiJFarokhzadOCInsight into nanoparticle cellular uptake and intracellular targetingJ Control Release201419048549924984011
- XuSOlenyukBZOkamotoCTHamm-AlvarezSFTargeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advancesAdv Drug Deliv Rev201365112113823026636
- SaraivaCPraçaCFerreiraRSantosTFerreiraLBernardinoLNanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseasesJ Control Release2016235344727208862
- LentingKVerhaakRter LaanMWesselingPLeendersWGlioma: experimental models and realityActa Neuropathol2017133226328228074274
- GerstnerERFineRLIncreased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigmJ Clin Oncol200725162306231217538177
- ZhangRDPriceJEFujimakiTBucanaCDFidlerIJDifferential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude miceAm J Pathol19921415111511241443046
- FormoloCAWilliamsRGordish-DressmanHMacDonaldTJLeeNHHathoutYSecretome signature of invasive glioblastoma multiformeJ Proteome Res20111073149315921574646
- ClaesAGambarotaGHamansBMagnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatmentInt J Cancer200812291981198618081012
- DawidczykCMRussellLMSearsonPCPerspective: recommendations for benchmarking pre-clinical studies of nanomedicinesCancer Res201575194016402026249177
- WangC-XHuangL-SHouL-BAntitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor modelBrain Res20091261919919401168
- GelperinaSMaksimenkoOKhalanskyADrug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parametersEur J Pharm Biopharm201074215716319755158
- IshiharaHKubotaHLindbergRLPEndothelial cell barrier impairment induced by glioblastomas and transforming growth factor β2 involves matrix metalloproteinases and tight junction proteinsJ Neuropathol Exp Neurol200867543544818431253
- ChertokBMoffatBADavidAEIron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumorsBiomaterials200829448749617964647
- BlancoEShenHFerrariMPrinciples of nanoparticle design for overcoming biological barriers to drug deliveryNat Biotechnol201533994195126348965
- AmoozgarZYeoYRecent advances in stealth coating of nanoparticle drug delivery systemsWiley Interdiscip Rev Nanomed Nanobiotechnol20124221923322231928
- GuLFangRHSailorMJParkJ-HIn vivo clearance and toxicity of monodisperse iron oxide nanocrystalsACS Nano2012664947495422646927
- WeiYZhaoMYangFMaoYXieHZhouQIron overload by superparamagnetic iron oxide nanoparticles is a high risk factor in cirrhosis by a systems toxicology assessmentSci Rep201662911027357559
- GarciaSCGuterresSSBubolsGBBulcãoRPCharãoMFPohlmannARPolymeric nanoparticles: in vivo toxicological evaluation, cardiotoxicity, and hepatotoxicityDuránNGuterresSSAlvesOLNanotoxicology: Materials, Methodologies, and AssessmentsNew YorkSpringer2014299324
- JainTKReddyMKMoralesMALeslie-PeleckyDLLabhasetwarVBiodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in ratsMol Pharm20085231632718217714
- DanhierFTo exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine?J Control Release2016244Pt A10812127871992